Stock Comparison
GMAB vs VRTX
Genmab AS and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$16.04B
$124.70B
P/E (TTM)
19.8
29.2
Forward P/E
15.6
25.8
Price/Sales
4.1
10.2
Price/Book
2.8
6.4
EV/EBITDA
15.3
24.0
Dividend Yield
—
—
Profitability
Net Margin
21.00%
35.50%
Operating Margin
25.10%
38.10%
Return on Equity
15.00%
24.20%
Return on Assets
8.48%
12.10%
Growth (YoY)
Revenue Growth
25.30%
7.80%
Earnings Growth
-72.80%
61.40%
Price & Risk
Beta
0.7
0.3
52-Week High
$35.43
$507.92
52-Week Low
$20.23
$362.50
Analyst Target
$36.82
$548.69
Compare GMAB and VRTX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.